GleamWall
中文EN

NAMS NewAmsterdam Pharma Co N.V.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1936258 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-26.4%
TTM net income YoY7.3%
TTM EPS YoY17.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-900.1%
Net margin-789.9%
FCF margin-581.6%
EBITDA margin-899.0%

Returns

ROE-30.2%
ROA-27.8%
ROIC (approx.)-92.8%
Asset turnover0.04x

Leverage & solvency

Liabilities / assets8.3%
Debt / equity0.00x
Current ratio11.76x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.73x
Accruals ratio-7.4%
Payout ratio—
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$22.50M$45.56M
R&D expense$141.83M$151.41M
SG&A expense$106.35M$70.45M
Operating income-$225.68M-$176.29M
Pretax income-$203.82M-$241.60M
Income tax—-$1,000
Net income-$203.82M-$241.60M
EBITDA-$225.46M-$176.18M
EPS (basic)-1.72-2.56
EPS (diluted)-1.72-2.56
Weighted avg. shares (diluted)118.42M94.36M
Balance sheet
Cash & equivalents$490.00M$771.74M
Short-term investments$146.24M$62.45M
Current assets$675.70M$863.41M
PP&E, net$383,000$242,000
Total assets$769.28M$864.62M
Current liabilities$85.79M$106.92M
Total liabilities$85.85M$107.12M
Shareholders' equity$683.43M$757.50M
Shares outstanding114.40M108.06M
Cash flow statement
Operating cash flow-$147.78M-$158.56M
Capital expenditure$246,000$672,000
Free cash flow-$148.03M-$159.24M
Investing cash flow-$174.92M-$62.85M
Financing cash flow$29.52M$659.51M
Depreciation & amortization$220,000$113,000
Stock-based compensation$59.42M$33.62M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.